STOCK TITAN

Techlott warned over sub-penny OTCQB share price

Techlott Inc. faces the risk of removal from the OTCQB Venture Market if it cannot lift its share price to required levels within a 90-day cure period.

(High)
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

Techlott Inc. (LOTT) reports that on July 28, 2026 it received a notice from OTC Markets Group that its common stock no longer meets the OTCQB Venture Market continued eligibility criteria because the closing bid price has been below $0.01 per share for more than 30 consecutive calendar days.

Under a 90-calendar-day cure period, the closing bid price must reach at least $0.01 per share for 10 consecutive trading days by October 26, 2026 to maintain OTCQB quotation. If the closing bid price is below $0.001 per share for five consecutive trading days, the common stock would be removed from the OTCQB Venture Market immediately, without any cure period.

Positive

  • None.

Negative

  • Risk of OTCQB removal: Techlott’s stock failed the OTCQB bid-price standard, triggering a 90-day cure period and creating a risk of delisting from the OTCQB Venture Market if price thresholds are not met.
Item 8.01 Other Events Other
Voluntary disclosure of events the company deems important to shareholders but not covered by other items.
Bid price threshold $0.01 per share Minimum closing bid price required under OTCQB continued eligibility standards
Consecutive days below threshold More than 30 days Period during which the closing bid was below $0.01 per share, triggering the notice
Cure period length 90 calendar days Time granted to regain compliance with OTCQB bid-price standards
Compliance trading-day requirement 10 consecutive trading days Days the closing bid must be at or above $0.01 per share during the cure period
Cure period deadline October 26, 2026 Date by which bid-price compliance must be achieved to avoid OTCQB removal
Immediate removal threshold $0.001 per share Closing bid price level that, if breached for five consecutive trading days, causes immediate OTCQB removal
Days for immediate removal Five consecutive trading days Duration below $0.001 per share that triggers immediate OTCQB removal
OTCQB Venture Market market
"no longer satisfied the continued eligibility criteria for quotation on the OTCQB Venture Market"
The OTCQB Venture Market is a tier of the over‑the‑counter (OTC) trading platform that groups early‑stage, smaller companies that do not meet the stricter requirements of higher OTC tiers. It gives investors a way to buy and sell shares in these higher‑risk, less mature firms with generally lower reporting and transparency standards; think of it as a marketplace’s “starter lane” where potential is available but uncertainty and volatility are higher, so investors should expect greater risk and do extra homework.
closing bid price financial
"the closing bid price of the Company’s common stock had been below $0.01 per share"
The closing bid price is the last price that a buyer was willing to pay for a security at the end of the trading day. It reflects the final visible demand for the stock — like the last offer someone makes for a used car before a yard closes — and helps investors gauge market interest, set valuations, and mark portfolios to market for that day.
continued eligibility criteria regulatory
"no longer satisfied the continued eligibility criteria for quotation on the OTCQB Venture Market"
cure period regulatory
"the Company was granted a cure period of 90 calendar days"
A cure period is a set amount of time given to a borrower, counterparty, or contracting party to fix a missed payment, breach, or other problem before more serious consequences—like penalties, higher interest, or contract termination—kick in. For investors, it matters because it creates a short grace window that can prevent immediate losses and influence the timing and likelihood of recovery; think of it like a few extra days to pay a bill before a service is cut off.
trading days market
"must be $0.01 per share or greater for 10 consecutive trading days"
Trading days are the specific days when a stock exchange is open and buying and selling of securities can occur, excluding weekends and exchange-declared holidays. Investors use trading days to measure performance, calculate settlement deadlines and time-sensitive events—think of them as the business hours calendar for markets, where returns, volumes and deadlines are counted only on days the market is operating.

FAQ

What triggered Techlott Inc. (LOTT) to receive an OTCQB deficiency notice?

Techlott received notice because the closing bid price of its common stock was below $0.01 per share for more than 30 consecutive calendar days, breaching OTCQB continued eligibility criteria.

What cure period has Techlott Inc. (LOTT) been given by OTCQB?

Techlott has a 90 calendar day cure period. During this time, its closing bid price must be at least $0.01 per share for 10 consecutive trading days to continue being quoted on the OTCQB Venture Market.

What is the deadline for Techlott Inc. (LOTT) to regain OTCQB compliance?

The company must satisfy the cure requirement by October 26, 2026. By that date, its closing bid price must have been at least $0.01 per share for 10 consecutive trading days.

What happens if Techlott Inc. (LOTT) does not meet the OTCQB cure requirement?

If Techlott does not achieve a closing bid price of at least $0.01 per share for 10 consecutive trading days by October 26, 2026, its common stock will be removed from quotation on the OTCQB Venture Market.

Under what condition could Techlott Inc. (LOTT) be removed from OTCQB immediately?

If the closing bid price of Techlott’s common stock falls below $0.001 per share for five consecutive trading days, the stock would be removed from the OTCQB Venture Market immediately, with no cure period.

On which market is Techlott Inc. (LOTT) currently quoted according to this report?

Techlott’s common stock is quoted on the OTCQB Venture Market, and the notice concerns its continued eligibility for quotation on that market.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
false 0001568969 0001568969 2026-07-28 2026-07-28 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): July 28, 2026

 

TECHLOTT INC.

(Exact name of registrant as specified in its charter)

 

Nevada   000-55403   46-1496846

(State or other jurisdiction

of incorporation)

 

(Commission

File Number)

 

(I.R.S. Employer

Identification No.)

 

16 Balfour Street, Jerusalem, Israel 9210207

(Address of principal executive offices) (Zip Code)

 

Registrant’s telephone number, including area code: (800) 674-3561

 

Not Applicable

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act: None.

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

 
 

 

Item 8.01 Other Events.

 

On July 28, 2026, Techlott Inc. (the “Company”) received notice from OTC Markets Group Inc. that the closing bid price of the Company’s common stock had been below $0.01 per share for more than 30 consecutive calendar days, and that the Company’s common stock therefore no longer satisfied the continued eligibility criteria for quotation on the OTCQB Venture Market set forth in Section 2.1(A) of the OTCQB Standards.

 

Under Section 4.1(B) of the OTCQB Standards, the Company was granted a cure period of 90 calendar days, during which the closing bid price of the Company’s common stock must be $0.01 per share or greater for 10 consecutive trading days in order for the common stock to continue to be quoted on the OTCQB Venture Market. If that requirement is not satisfied by October 26, 2026, the common stock will be removed from the OTCQB Venture Market.

 

In the event the closing bid price of the common stock is below $0.001 per share for five consecutive trading days, the common stock would be removed from the OTCQB Venture Market immediately, without any cure period.

 

 
 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

TECHLOTT INC.

 

Date: September 4, 2026

 

By: /s/ Yakir Abadi  
Name: Yakir Abadi  
Title: Chief Executive Officer  

 

 

 

Filing Exhibits & Attachments

3 documents

Keep reading